Defining more than just a number

In rare diseases and oncology, pricing must strike a delicate balance of rewarding value, enabling access, and supporting innovation, all under intense scrutiny.

Pricing requires methodological rigour, creativity and strategic clarity. We recognise the need to go beyond research and consider different perspectives and analytical approaches.

At Prescient, we help our clients navigate complexity with confidence to craft a robust and communicable price strategy – credible from the boardroom to the negotiating table.